Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (341-350 of 498) with videos related to

Pageof 50
Sort By:
Nature Communications|February 11, 2021
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomesAdam B Weiner, Thiago Vidotto, Yang Liu, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
JAMA Oncology|October 29, 2020
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 PandemicHolly E Hartman, Yilun Sun, Theresa P Devasia, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
The Journal of Urology|October 20, 2020
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing ApproachJeffrey J Tosoian, Bruce J Trock, Todd M Morgan, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.
BJU International|March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping systemDaniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Pageof 50

Showing results (341-350 of 498) with videos related to

Sort By:
Pageof 50
Nature Communications|February 11, 2021
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomesAdam B Weiner, Thiago Vidotto, Yang Liu, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
JAMA Oncology|October 29, 2020
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 PandemicHolly E Hartman, Yilun Sun, Theresa P Devasia, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
The Journal of Urology|October 20, 2020
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing ApproachJeffrey J Tosoian, Bruce J Trock, Todd M Morgan, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
Medical Oncology (Northwood, London, England)|February 2, 2018
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissectionsDaniel E Spratt, Krithika Suresh, Takahiro Osawa, et al.
Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.
BJU International|March 25, 2016
Independent surgical validation of the new prostate cancer grade-grouping systemDaniel E Spratt, Adam I Cole, Ganesh S Palapattu, et al.
Pageof 50